Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who are over 20 years old and have been diagnosed with type 2 diabetes (2) Patients who are currently visiting the hospital and receiving drug treatment with diabetic drugs (3) Patients whose HbA1c level was measured within 6 months before the start of the research (4) Patients who have given their voluntary consent to participate in the research
Exclusion criteria
Exclusion criteria: (1) Patients who cannot confirm the use of diabetes medicine (2) Patients whose HbA1c level cannot be confirmed within 6 months before the start of the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Glycemic control (achieved / unachieved) 2) Awareness of diabetes treatment 3) Satisfaction with diabetes treatment 4) Compliance with drug treatment 5) Motivation for treatment 6) Anxiety about diabetes treatment 7) Flail 8) The potential of sarcopenia 9) Fall 10) Hypoglycemic symptoms 11) Cognitive function (memory, orientation), instrumental ADL and basic ADL | — |
Countries
Japan
Contacts
3H Clinical Trial Inc. Inquiry counter of Seikatu Kojo WEB